Received Oct 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | IM |
felling very achy; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (felling very achy) in a 34-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Oct-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On 16-Oct-2025, after starting mRNA-1273.251 (Spikevax LP.8.1 PFS), the patient experienced MYALGIA (felling very achy). At the time of the report, MYALGIA (felling very achy) outcome was unknown. The action taken with mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) was unknown. Concomitant medications were not reported. It was reported that patient received the vaccine on 15-Oct-2025, and woke up at 4 a.m. feeling very achy. No other additional details were provided. It was unknown if the patient experienced any additional symptoms/events. Treatment information was not reported.